Levomont 10,0 mg/5,0 mg Fim-coated tablets
PDF Leaflet Revision Date: October 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Relief of symptoms associated with seasonal allergic rhinitis in adults.
Dosage (summary)
One tablet orally in the evening for adults; not recommended for patients under 18.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety not established; montelukast may be excreted in milk.
Key Drug Interactions
- Caution with CYP3A4 inducers
- Avoid alcohol
Contraindications
- Hypersensitivity to components
- Severe renal impairment (<10 mL/min)
Common side effects
- Headache
- Dizziness
- Somnolence
- Dry mouth
Counselling Points
- Take in the evening
- Avoid alcohol
- Report any mood changes
Serious warnings
- Not for acute asthma attacks
- Risk of neuropsychiatric events
Important Disclaimer
The Levomont 10,0 mg/5,0 mg Fim-coated tablets professional information leaflet below is the property of Forrester Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
